Sánchez-González M, Colom H, Lozano-Mena G, Juan ME, Planas JM. Population pharmacokinetics of maslinic acid, a triterpene from olives, after intravenous and oral administration in rats.
Mol Nutr Food Res 2014;
58:1970-9. [PMID:
25045029 DOI:
10.1002/mnfr.201400147]
[Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2014] [Revised: 06/02/2014] [Accepted: 06/27/2014] [Indexed: 12/19/2022]
Abstract
SCOPE
Maslinic acid is a bioactive minor component of Olea europaea L. with health-enhancing activities and no harmful effects. A pharmacokinetic (PK) study was conducted to determine its bioavailability for future studies of maslinic acid in humans.
METHODS AND RESULTS
Intravenous (1 mg/kg) and oral (50 mg/kg) administrations to Sprague-Dawley rats were performed. Blood was obtained several times over 24 h and PKs were analyzed with NONMEM 7.2, applying a population approach. Body weight was included a priori in the model with fixed allometric exponents, based on allometric principles. Plasma concentrations versus time were best characterized by a two-open compartment model with first-order absorption and linear elimination. Maslinic acid had a relative rapid oral absorption with a peak concentration after administration at 0.51 h and a bioavailability of 5.13%. Once in bloodstream, it distributed extensively into tissues, since the central and peripheral distribution volumes were 8.41 L/70 kg and 63.6 L/70 kg, respectively. The clearance (8 L/h/70 kg) was related to unaltered renal excretion. The prediction-corrected visual predictive check confirmed its stability and predictive ability.
CONCLUSION
An allometric population PK model was performed for maslinic acid, which adequately described and predicted plasma concentrations.
Collapse